CASS研究:氰基丙烯酸酯闭合术与手术剥脱术治疗大隐静脉功能不全的随机对照试验
本研究为开放标签、多中心、前瞻性随机对照试验,旨在证明氰基丙烯酸酯闭合术(VenaSeal™系统)治疗大隐静脉功能不全的临床结局不劣于手术剥脱术。主要终点为治疗后3个月经多普勒超声评估的靶静脉完全闭合率(闭合组)或无静脉反流/残留静脉组织(剥脱组)。
要点
- 氰基丙烯酸酯闭合术对比手术剥脱术治疗大隐静脉功能不全的非劣效性随机对照试验。
- 主要终点为3个月时多普勒超声评估的靶静脉完全闭合率或无静脉反流/残留静脉组织。
- 次要终点包括围手术期疼痛、术后瘀斑、生活质量、12和24个月闭合率及24个月不良事件率。
核心结论
- 该试验旨在证明氰基丙烯酸酯闭合术在靶静脉完全闭合率方面不劣于手术剥脱术。
研究设计与样本
- 开放标签、多中心、前瞻性随机对照试验,参与者随机分配至氰基丙烯酸酯闭合组或手术剥脱组。
关键数值与推荐
- 主要终点:氰基丙烯酸酯闭合组靶静脉完全闭合率,手术剥脱组无静脉反流或残留静脉组织,于治疗后3个月经多普勒超声评估。
- 次要终点:围手术期疼痛、术后瘀斑、临床评估(包括通用和疾病特异性生活质量)、12和24个月随访时的完全闭合率及无静脉反流或残留静脉组织、24个月随访期间所有不良事件率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several modalities are used for the treatment of varicose veins. Open surgical treatment with ligation and stripping of the saphenous vein has been the standard of care for many years. Endovenous thermal ablation has been shown to be a safe and effective alternative with high, long-term, target-vein closure rates. Despite this, there is the possibility of thermal injury to surrounding structures. The recently introduced cyanoacrylate closure is also considered to be a good alternative and the risk of injury to surrounding structures is minimal. The purpose of this study is to demonstrate the non-inferiority of cyanoacrylate closure with the VenaSeal™ closure system compared to surgical stripping in terms of clinical outcomes for the treatment of incompetent great saphenous veins. METHODS/DESIGN: This is an open-label, multicenter, prospective, randomized controlled trial evaluating the non-inferior clinical outcomes of cyanoacrylate closure compared to surgical stripping for the treatment of incompetent saphenous veins. After baseline measurements, participants will be randomly allocated into either the cyanoacrylate closure group or the surgical-stripping group. The primary endpoint of the study is the complete closure rate of the target vein in the cyanoacrylate closure group, and the absence of venous reflux or residual venous tissue after surgical stripping in the surgical-stripping group. These endpoints will be measured by Doppler ultrasound performed by qualified vascular technologists or investigators at 3 months after treatment. Secondary outcomes include perioperative pain, postoperative ecchymosis, clinical assessment (including general and disease-specific quality of life evaluations), complete closure rate, and absence of venous reflux or residual venous tissue at the 12- and 24-month follow-ups, as well as all adverse event rates during the 24-month follow-up period. DISCUSSION: This multicenter randomized controlled trial is designed to show non-inferiority in terms of complete closure rate of cyanoacrylate compared to surgical stripping for the treatment of incompetent saphenous veins. TRIAL REGISTRATION: Clinical Research Information Service (CRIS), ID: KCT0003203. Registered on 20 September 2018.
引用
- Cho S, Park HS, Lee T, et al. CASS (CyanoAcrylate closure versus Surgical Stripping for incompetent saphenous veins) study: a randomized controlled trial comparing clinical outcomes after cyanoacrylate closure and surgical stripping for the treatment of incompetent saphenous veins. Trials. 2020. PMID: 32493398. doi:10.1186/s13063-020-04393-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。